CS logo
small CS logo
Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen

Tubingen, Baden-Württemberg, Germany
Research institute in Tübingen, Baden-Württemberg
Elfriede-Aulhorn-Straße 7, 72076 Tübingen

About Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen


During the past decade, Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen" #1 collaborator was "Haag-Streit AG" with 2 trials as a collaborator, "University Hospital Tuebingen" with 2 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

Clinical Trials Conditions at Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen


According to Clinical.Site data, the most researched conditions in "Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen" are "LCA (Leber Congenital Amaurosis)" (2 trials), "RP (Retinitis Pigmentosa)" (2 trials), "Achromatopsia" (1 trials), "Choroideremia" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen" in a lesser frequency.

Clinical Trials Intervention Types at Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen


Most popular intervention types in "Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen" are "Device" (3 trials), "Drug" (3 trials), "Genetic" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "QLT091001" (2 trials), "perimetry" (2 trials), "D-BCVA" (1 trials), "Fundus photography" (1 trials) and "IOP" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen


The vast majority of trials in "Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen" are 8 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen


Currently, there are NaN active trials in "Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".